
结论很明确:这个市场不适合进入。 目前不是超饱和的“品牌洪水”市场,但已经进入明显的同质化价格战,最赚钱的新品牌样本只有 Omnismei 的单款成功,复制性很弱;对小卖家和大品牌来说都不是高胜率赛道。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
这不是一个适合进入的市场。 目前看它已经接近价格战区,且新品牌成功样本太少:新品牌 Omnismei 只有 1 个新产品盈利、1 个新产品亏损,成功率 50%,但样本只有 2 个,不能代表市场整体;更关键的是,老品牌 VOYOR-HEALTH 作为旧品牌样本里 2 个产品全部不盈利,说明靠常规配置很难打穿。用户预算 500,000 CNY 只能覆盖前期上架和起量,够做单个 ASIN 的入场测试,但不足以支撑长期研发、品牌和认证投入。
Some categories may not originally require certain certificates for entry; however, some products may target specific features (e.g. Bluetooth) or customers (e.g. children), and additional certificates may be required in the target marketplace (e.g. FCC, CPC).
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不值得进入:不是增量市场,而是典型的同质化价格战。 现有样本里,只有1个可判定盈利的产品,整体盈利率仅25.00%;新品牌样本里盈利与亏损各占50.00%,但真正撑起利润的只有 Omnismei 的 B0FNWTX377,而老品牌 VOYOR-HEALTH 的两个样本全部不盈利,说明这条赛道对“常规款”极不友好。
这个市场不该进。 当前样本里只有2个新品牌/旧品牌样本,表面成功率看起来不低,但真实可复制性很弱;更关键的是,盈利产品几乎只剩一个新品牌 Omnismei 的单点成功,另一条新产品已经亏损,说明这不是稳定机会,而是靠单款爆发撑起来的市场。
证据很直接: 新品盈利率只有50%,非盈利率也是50%;全部可识别利润样本里,盈利产品仅25%,也就是说大多数产品并不赚钱。唯一明确赚钱的新产品是 B0FNWTX377(Omnismei),售价 $19.57,月销600件,月营收 $11,742,利润率19.6%,最近月利润 $2,296.74,早期投入约 $10,604.20,其中广告约 $2,383.82。反过来,同品牌的 B0FZSXP23F 已经亏损,旧品牌 VOYOR-HEALTH 还有 B0CC8887JS 这种 31.77% 但不赚钱的老产品,说明高毛利不等于可复制,且老品牌更像大品牌防守位,不是小卖家案例。按你的规则,这里没有 30~100+ 新品牌涌入的超饱和证据,但也完全没有形成适合新卖家的稳定胜率;从时间趋势看,2025 年才出现这两条新产品,说明市场是刚被试探进入,不是成熟放量赛道,但目前的结果是“一个成、一个败”,波动太大。
结论: 大品牌可以用更高预算和品牌力硬冲,但也只是“可能”,不是高胜率;小卖家不适合进,因为可参考的真成功案例太少,而且这类成功不清楚是否依赖创新、品牌或更高投放,500000 CNY 预算虽然够单品启动,但不足以证明你能复制 Omnismei 的结果。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B0FNWTX377 | Omnismei | 2025-09-28 | Yes | $19.57 | 600pcs | $11742.0 | 19.56% | $2296.74 |
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
![]() | B0FNWTX377 | Omnismei | 2025-09-28 | Yes | $19.57 | 600pcs | $11742.0 | 19.56% | $2296.74 |
这个市场不值得进,原因很直接:新品牌真实成功案例极少,价格和同质化都在把利润压薄。 目前能看到的有效样本里,只有 Omnismei 的 B0FNWTX377 跑通了,月销约600、月营收约117.42万日元/美元口径数据中显示为 1174200,利润率 19.56%,但它是靠“基于旧款做差异化+低价”才赢的;反过来,同品牌的 B0FZSXP23F 直接失败,而老牌 VOYOR-HEALTH 的 B0CC8887JS、B0CY2R8W55 也都没跑通,说明这不是一个靠普通上新就能赢的市场。当前可识别盈利率只有 25%,新上新盈利率 50% 只是因为样本极少,不能当成可复制的好信号。
What is the ratio of profitable products
What is the ratio of different brands owning all profitable new products
What is the ratio of different brands owning all nonprofitable new products
这个市场不值得进入:它已经进入明显的价格战早期,且新品牌成功率只有50%,目前看到的“成功”样本太少,不足以证明市场对新进入者友好。 现有数据里,真正可复制的只是 Omnismei 的单一成功款 B0FNWTX377,而它的失败款 B0FZSXP23F 则直接说明新品牌一旦没有跑通流量和转化,结果会迅速掉到不可做。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/9 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |